Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) - Kosiborod, M; Cavender, MA; Fu, AZ (Circulation, 2017)
doi:10.1161/CIRCULATIONAHA.117.029190